Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05835895
PHASE1

Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis

Sponsor: Genascence Corporation

View on ClinicalTrials.gov

Summary

The goal of this clinical study is to determine if a single injection of 1 or more dose levels of adeno-associated virus (AAV) gene therapy (GNSC-001) is safe and tolerated compared to placebo in participants with painful osteoarthritis (OA) of the knee.

Official title: A Phase 1b, Randomized, Double-Blinded, Placebo-Controlled Dose Ranging Study to Evaluate Safety, Tolerability and Pharmacodynamics of a Single Intra-articular Injection of GNSC-001 Gene Therapy in Subjects With Osteoarthritis of the Knee

Key Details

Gender

All

Age Range

40 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

67

Start Date

2023-06-12

Completion Date

2029-05

Last Updated

2025-08-01

Healthy Volunteers

No

Interventions

GENETIC

GNSC-001

intra-articular injection

DRUG

transient immune-modulation

oral

DRUG

transient immune-modulation

intra-articular injection

DRUG

Placebo

intra-articular injection

Locations (9)

Alliance for Medical Research Mobile

Mobile, Alabama, United States

Biosolutions Clinical Research Center

La Mesa, California, United States

UC San Diego

San Diego, California, United States

Well Pharma Medical Research

Miami, Florida, United States

South Florida Research

Miami Springs, Florida, United States

Premier Medical Associates

The Villages, Florida, United States

Alliance for Multispecialty Research Kansas City

Kansas City, Missouri, United States

West Clinical Research

Morehead City, North Carolina, United States

Altoona Center for Clinical Research

Duncansville, Pennsylvania, United States